Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yusko EC"'
Autor:
Ramien C; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Yusko EC; Adaptive Biotechnologies Corp., 1551 Eastlake Ave. E., Seattle, WA 98102, USA., Engler JB; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Gamradt S; Charité - Universitätsmedizin Berlin, Klinik für Psychiatrie und Medizinische Klinik m.S. Psychosomatik, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany., Patas K; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany; Laboratory for Biopathology and Immunology, Eginition University Hospital, 72-74 Vasilissis Sophias Ave., 11528 Athens, Greece., Schweingruber N; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany; Klinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Willing A; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Rosenkranz SC; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany; Klinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Diemert A; Klinik für Geburtshilfe und Pränatalmedizin, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Harrison A; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany; Department of Psychology, University of Central Lancashire, Preston, PR1 2HE Lancashire, UK., Vignali M; Adaptive Biotechnologies Corp., 1551 Eastlake Ave. E., Seattle, WA 98102, USA., Sanders C; Adaptive Biotechnologies Corp., 1551 Eastlake Ave. E., Seattle, WA 98102, USA., Robins HS; Adaptive Biotechnologies Corp., 1551 Eastlake Ave. E., Seattle, WA 98102, USA; Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA 98109-1024, USA., Tolosa E; Institut für Immunologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Heesen C; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany; Klinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Arck PC; Labor für Experimentelle Feto-Maternale Medizin, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Scheffold A; Institut für Immunologie, Universitätsklinikum Schleswig-Holstein, Arnold Heller Str. 3, 24105 Kiel, Germany., Chan K; Adaptive Biotechnologies Corp., 1551 Eastlake Ave. E., Seattle, WA 98102, USA., Emerson RO; Adaptive Biotechnologies Corp., 1551 Eastlake Ave. E., Seattle, WA 98102, USA., Friese MA; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany., Gold SM; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany; Charité - Universitätsmedizin Berlin, Klinik für Psychiatrie und Medizinische Klinik m.S. Psychosomatik, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany. Electronic address: stefan.gold@charite.de.
Publikováno v:
Cell reports [Cell Rep] 2019 Oct 22; Vol. 29 (4), pp. 810-815.e4.
Autor:
Khunger A; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, WA, USA., Fields P; Adaptive Biotechnologies, Seattle, WA, USA., Yusko EC; Adaptive Biotechnologies, Seattle, WA, USA., Tarhini AA; Department of Cutaneous Oncology, Moffitt Comprehensive Cancer Center, Tampa, Florida, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2019 Aug 20; Vol. 8 (11), pp. e1652538. Date of Electronic Publication: 2019 Aug 20 (Print Publication: 2019).
Autor:
Agdashian D; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., ElGindi M; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Xie C; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Sandhu M; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Pratt D; Laboratory of Pathology, Center for Cancer Research (CCR) National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kleiner DE; Laboratory of Pathology, Center for Cancer Research (CCR) National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, WA, USA., Sanders C; Adaptive Biotechnologies, Seattle, WA, USA., Yusko EC; Adaptive Biotechnologies, Seattle, WA, USA., Wood B; Center for Interventional Oncology, Radiology and Imaging Sciences and Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Venzon D; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Brar G; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Duffy AG; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Greten TF; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA. tim.greten@nih.gov.; NCI CCR Liver Cancer Program, Bethesda, MD, USA. tim.greten@nih.gov., Korangy F; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Apr; Vol. 68 (4), pp. 599-608. Date of Electronic Publication: 2019 Jan 28.
Autor:
Tarhini A; UPMC Hillman Cancer Center, Pittsburgh, USA. tarhina1@ccf.org.; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute and Case Comprehensive Cancer Center, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA. tarhina1@ccf.org., Lin Y; UPMC Hillman Cancer Center, Pittsburgh, USA., Lin H; UPMC Hillman Cancer Center, Pittsburgh, USA., Rahman Z; UPMC Hillman Cancer Center, Pittsburgh, USA., Vallabhaneni P; UPMC Hillman Cancer Center, Pittsburgh, USA., Mendiratta P; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute and Case Comprehensive Cancer Center, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA., Pingpank JF; UPMC Hillman Cancer Center, Pittsburgh, USA., Holtzman MP; UPMC Hillman Cancer Center, Pittsburgh, USA., Yusko EC; Adaptive Biotechnologies, Seattle, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, USA., Rao UNM; UPMC Hillman Cancer Center, Pittsburgh, USA., Ferris RL; UPMC Hillman Cancer Center, Pittsburgh, USA., Kirkwood JM; UPMC Hillman Cancer Center, Pittsburgh, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Oct 23; Vol. 6 (1), pp. 112. Date of Electronic Publication: 2018 Oct 23.
Autor:
Hopkins AC; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Yarchoan M; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Durham JN; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Yusko EC; Adaptive Biotechnologies, Seattle, Washington, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, Washington, USA., Robins HS; Adaptive Biotechnologies, Seattle, Washington, USA., Laheru DA; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Le DT; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Lutz ER; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Jaffee EM; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA.
Publikováno v:
JCI insight [JCI Insight] 2018 Jul 12; Vol. 3 (13). Date of Electronic Publication: 2018 Jul 12.
Autor:
Wrangle JM; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Velcheti V; Cleveland Clinic, Cleveland, OH, USA., Patel MR; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA., Garrett-Mayer E; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Hill EG; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Ravenel JG; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Miller JS; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA., Farhad M; Earle A Chiles Research Institute, Portland, OR, USA., Anderton K; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Lindsey K; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Taffaro-Neskey M; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Sherman C; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Suriano S; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Swiderska-Syn M; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Sion A; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Harris J; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Edwards AR; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, WA, USA., Sanders CM; Adaptive Biotechnologies, Seattle, WA, USA., Yusko EC; Adaptive Biotechnologies, Seattle, WA, USA., Robinson MD; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland., Krieg C; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Redmond WL; Earle A Chiles Research Institute, Portland, OR, USA., Egan JO; Altor BioScience, Miramar, FL, USA., Rhode PR; Altor BioScience, Miramar, FL, USA., Jeng EK; Altor BioScience, Miramar, FL, USA., Rock AD; Altor BioScience, Miramar, FL, USA., Wong HC; Altor BioScience, Miramar, FL, USA., Rubinstein MP; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA. Electronic address: markrubinstein@musc.edu.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 May; Vol. 19 (5), pp. 694-704. Date of Electronic Publication: 2018 Apr 05.
Autor:
Reuben A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gittelman R; Adaptive Biotechnologies, Seattle, Washington., Gao J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yusko EC; Adaptive Biotechnologies, Seattle, Washington., Wu CJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Emerson R; Adaptive Biotechnologies, Seattle, Washington., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tipton C; Adaptive Biotechnologies, Seattle, Washington., Li J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Quek K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gopalakrishnan V; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chen R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vence LM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cascone T; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vignali M; Adaptive Biotechnologies, Seattle, Washington., Fujimoto J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rodriguez-Canales J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Little LD; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Federico L; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Behrens C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Benzeno S; Adaptive Biotechnologies, Seattle, Washington., Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sepesi B; Department of Thoracic Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gibbons DL; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., William WN Jr; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Swisher S; Department of Thoracic Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Robins H; Adaptive Biotechnologies, Seattle, Washington.; Department of Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington., Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sharma P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. jzhang20@mdanderson.org iiwistuba@mdanderson.org afutreal@mdanderson.org., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. jzhang20@mdanderson.org iiwistuba@mdanderson.org afutreal@mdanderson.org., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. jzhang20@mdanderson.org iiwistuba@mdanderson.org afutreal@mdanderson.org.; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer discovery [Cancer Discov] 2017 Oct; Vol. 7 (10), pp. 1088-1097. Date of Electronic Publication: 2017 Jul 21.
Autor:
Dovedi SJ; Targeted Therapy Group, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, Christie Hospital, Manchester Academic Health Sciences Centre, United Kingdom. DovediSi@MedImmune.com Tim.Illidge@manchester.ac.uk.; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Cheadle EJ; Targeted Therapy Group, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, Christie Hospital, Manchester Academic Health Sciences Centre, United Kingdom., Popple AL; Targeted Therapy Group, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, Christie Hospital, Manchester Academic Health Sciences Centre, United Kingdom., Poon E; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Morrow M; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Stewart R; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Yusko EC; Adaptive Biotechnologies, Seattle, Washington., Sanders CM; Adaptive Biotechnologies, Seattle, Washington., Vignali M; Adaptive Biotechnologies, Seattle, Washington., Emerson RO; Adaptive Biotechnologies, Seattle, Washington., Robins HS; Fred Hutchinson Cancer Research Center, Seattle, Washington., Wilkinson RW; MedImmune Ltd., Granta Park, Cambridge, United Kingdom., Honeychurch J; Targeted Therapy Group, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, Christie Hospital, Manchester Academic Health Sciences Centre, United Kingdom., Illidge TM; Targeted Therapy Group, Division of Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, Christie Hospital, Manchester Academic Health Sciences Centre, United Kingdom. DovediSi@MedImmune.com Tim.Illidge@manchester.ac.uk.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Sep 15; Vol. 23 (18), pp. 5514-5526. Date of Electronic Publication: 2017 May 22.
Autor:
Fong KK; Department of Biochemistry, University of Washington, Seattle, WA 98195., Sarangapani KK; Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195., Yusko EC; Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195., Riffle M; Department of Biochemistry, University of Washington, Seattle, WA 98195., Llauró A; Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195., Graczyk B; Department of Biochemistry, University of Washington, Seattle, WA 98195., Davis TN; Department of Biochemistry, University of Washington, Seattle, WA 98195., Asbury CL; Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195 casbury@uw.edu.
Publikováno v:
Molecular biology of the cell [Mol Biol Cell] 2017 Jul 07; Vol. 28 (14), pp. 1853-1861. Date of Electronic Publication: 2017 Mar 22.
Autor:
Yusko EC; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, USA., Bruhn BR; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, USA., Eggenberger OM; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, USA.; Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, CH-1700 Fribourg, Switzerland., Houghtaling J; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, USA.; Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, CH-1700 Fribourg, Switzerland., Rollings RC; Department of Physics, University of Arkansas, Fayetteville, Arkansas 72701, USA., Walsh NC; Department of Physics, University of Arkansas, Fayetteville, Arkansas 72701, USA., Nandivada S; Department of Physics, University of Arkansas, Fayetteville, Arkansas 72701, USA., Pindrus M; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, USA., Hall AR; Department of Biomedical Engineering and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA., Sept D; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, USA.; Center for Computational Medicine and Biology, University of Michigan, Ann Arbor, Michigan 48109, USA., Li J; Department of Physics, University of Arkansas, Fayetteville, Arkansas 72701, USA., Kalonia DS; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, USA., Mayer M; Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, USA.; Adolphe Merkle Institute, University of Fribourg, Chemin des Verdiers 4, CH-1700 Fribourg, Switzerland.; Biophysics Program, University of Michigan, Ann Arbor, Michigan 48109, USA.
Publikováno v:
Nature nanotechnology [Nat Nanotechnol] 2017 May; Vol. 12 (4), pp. 360-367. Date of Electronic Publication: 2016 Dec 19.